Probe Based Confocal Laser Endomicroscopy During Thoracoscopy for Pleural Carcinomatosis Diagnosis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03805971|
Recruitment Status : Recruiting
First Posted : January 16, 2019
Last Update Posted : February 21, 2019
|Condition or disease||Intervention/treatment|
|Pleural Carcinomatosis||Device: Study of the pleural cavity with a confocal laser endomicroscope.|
|Study Type :||Observational|
|Estimated Enrollment :||60 participants|
|Official Title:||Probe Based Confocal Laser Endomicroscopy During Thoracoscopy for Pleural Carcinomatosis Diagnosis|
|Actual Study Start Date :||May 22, 2018|
|Estimated Primary Completion Date :||December 20, 2019|
|Estimated Study Completion Date :||December 20, 2019|
patient aged more than 18 years admitted for thoracoscopy
Probe based confocal laser endomicroscopy (Mauna kea technologies) will be used, after intravenous fluorescein injection, for every patients admitted for medical thoracoscopy, to study the pleural cavity. Images will be compared with biopsies
Device: Study of the pleural cavity with a confocal laser endomicroscope.
Probe based confocal laser endomicroscope can be introduced through the working chanel of the thoracoscope. this allows the study of the pleural cavity with this new tool.
- Pleural carcinomatosis identification (compared to standard biopsies) [ Time Frame: One day. ]Ability of confocal endomicroscopy to identify pleural carcinomatosis with comparison to standard histological studies.
Biospecimen Retention: None Retained
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03805971
|Contact: Olivier Bonhomme, MDfirstname.lastname@example.org|
|Contact: Bernard Duysinx, PhDemail@example.com|
|CHU de Liège||Recruiting|
|Liège, Belgium, 4000|
|Contact: Olivier Bonhomme, MD|
|Principal Investigator:||Olivier Bonhomme, MD||CHU de Liège|